Sensitivity of Human Malignant Melanoma Cell Lines to Newcastle Disease Virus
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2015-10-01 / Anticancer Res. 2015 Oct;35(10):5401-6Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-09-29 / Oncotarget 2015 Sep;6(29):27751-62A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-09-15 / Oncotarget 2015 Sep;6(27):23462-79Electro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis
/in Glioblastoma, Hyperthermia, International Publications /von 2015-09-14 / Int J Hyperthermia 2015;31(7):784-92Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2015-09-11 / Oncoimmunology 2016 Feb;5(2):e1083669A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
/in Dendritic Cells, Exosome, International Publications /von 2015-09-10 / Bioimpacts 2015;5(3):117-22Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer
/in Esophageal Carcinoma, Hyperthermia, International Publications /von 2015-09-08 / Oncol. Rep. 2015 Nov;34(5):2656-64Immunotherapy of Brain Tumors
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2015-09-04 / Prog Tumor Res 2015;42:11-21Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
/in Checkpoint-Inhibitors, International Publications /von 2015-09-01 / Cancer Biol Med 2015 Sep;12(3):201-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de